MX2009006949A - Composiciones farmaceuticas inyectables liofilizadas de derivados semi-sinteticos de los alcaloides de vinca estables a temperatura ambiente. - Google Patents

Composiciones farmaceuticas inyectables liofilizadas de derivados semi-sinteticos de los alcaloides de vinca estables a temperatura ambiente.

Info

Publication number
MX2009006949A
MX2009006949A MX2009006949A MX2009006949A MX2009006949A MX 2009006949 A MX2009006949 A MX 2009006949A MX 2009006949 A MX2009006949 A MX 2009006949A MX 2009006949 A MX2009006949 A MX 2009006949A MX 2009006949 A MX2009006949 A MX 2009006949A
Authority
MX
Mexico
Prior art keywords
room temperature
freeze
pharmaceutical combination
vinca alkaloids
injectable pharmaceutical
Prior art date
Application number
MX2009006949A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Dominique Ibarra
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006949(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2009006949A publication Critical patent/MX2009006949A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención concierne a composiciones farmacéuticas que comprenden un derivado hidrosoluble semi-sintético del alcaloide de la vinca, estables a la temperatura ambiente, en los cuales dicho derivado está presente bajo la forma de un liofilizado obtenido en presencia de por lo menos un carbohidrato.
MX2009006949A 2006-12-29 2007-12-28 Composiciones farmaceuticas inyectables liofilizadas de derivados semi-sinteticos de los alcaloides de vinca estables a temperatura ambiente. MX2009006949A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
US89705907P 2007-01-24 2007-01-24
PCT/EP2007/064612 WO2008080968A1 (en) 2006-12-29 2007-12-28 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Publications (1)

Publication Number Publication Date
MX2009006949A true MX2009006949A (es) 2009-07-14

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006949A MX2009006949A (es) 2006-12-29 2007-12-28 Composiciones farmaceuticas inyectables liofilizadas de derivados semi-sinteticos de los alcaloides de vinca estables a temperatura ambiente.

Country Status (24)

Country Link
US (1) US8304424B2 (es)
EP (1) EP2120934B1 (es)
JP (1) JP2010514737A (es)
KR (1) KR20090097883A (es)
CN (1) CN101534821B (es)
AR (1) AR064715A1 (es)
AU (1) AU2007341231B2 (es)
BR (1) BRPI0722076A2 (es)
CA (1) CA2673232A1 (es)
CL (1) CL2007003838A1 (es)
FR (1) FR2910812B1 (es)
HK (1) HK1130439A1 (es)
IL (1) IL199556A (es)
MA (1) MA30892B1 (es)
MX (1) MX2009006949A (es)
NO (1) NO20092726L (es)
NZ (1) NZ576583A (es)
RU (1) RU2449791C2 (es)
SA (1) SA07280720B1 (es)
TN (1) TN2009000258A1 (es)
TW (1) TWI415631B (es)
UA (1) UA96977C2 (es)
WO (1) WO2008080968A1 (es)
ZA (1) ZA200903115B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
AU2019331886B2 (en) * 2018-08-31 2023-10-19 FUJIFILM Irvine Scientific, Inc. Venting system for a mixing apparatus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HUT54308A (en) * 1989-04-04 1991-02-28 Lilly Co Eli Process for producing immunoglobulin conjugates and medicaments comprising same
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
PL205936B1 (pl) * 2002-02-22 2010-06-30 Schering Corp Farmaceutyczny preparat zawierający termozolomid oraz sposób jego wytwarzania
FR2863891B1 (fr) 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
KR101462825B1 (ko) * 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
CA2602089C (en) * 2005-03-14 2013-04-30 Wyeth Tigecycline compositions and methods of preparation

Also Published As

Publication number Publication date
US8304424B2 (en) 2012-11-06
ZA200903115B (en) 2010-04-28
UA96977C2 (ru) 2011-12-26
KR20090097883A (ko) 2009-09-16
CL2007003838A1 (es) 2008-07-04
AR064715A1 (es) 2009-04-22
TWI415631B (zh) 2013-11-21
AU2007341231A1 (en) 2008-07-10
TW200833369A (en) 2008-08-16
RU2449791C2 (ru) 2012-05-10
TN2009000258A1 (en) 2010-10-18
IL199556A (en) 2014-09-30
FR2910812B1 (fr) 2009-03-20
WO2008080968A1 (en) 2008-07-10
JP2010514737A (ja) 2010-05-06
HK1130439A1 (en) 2009-12-31
RU2009128327A (ru) 2011-02-10
EP2120934B1 (en) 2014-05-07
EP2120934A1 (en) 2009-11-25
CN101534821B (zh) 2012-01-25
AU2007341231B2 (en) 2013-03-21
NO20092726L (no) 2009-07-20
MA30892B1 (fr) 2009-11-02
US20100087473A1 (en) 2010-04-08
BRPI0722076A2 (pt) 2014-04-08
SA07280720B1 (ar) 2012-02-07
NZ576583A (en) 2012-01-12
FR2910812A1 (fr) 2008-07-04
CN101534821A (zh) 2009-09-16
CA2673232A1 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
NO20084703L (no) Triazolopyrazinforbindelser nyttige for behandling av degenerative og inflammatoriske sykdommer
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
WO2006119498A3 (en) Pharmaceutical compositions with synchronized solubilizer release
WO2006101940A3 (en) Composition comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
WO2006076620A3 (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2008073448A3 (en) Pharmaceutical formulations and methods for making the same
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
IL190915A0 (en) Dry formulations of aripiprazole
MX2009006949A (es) Composiciones farmaceuticas inyectables liofilizadas de derivados semi-sinteticos de los alcaloides de vinca estables a temperatura ambiente.
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
TN2009000447A1 (en) An extented-release composition comprising a somatostatin derivative in microparticles
EA200970509A1 (ru) Композиции конъюгатов пэг-интерферон альфа
ZA200905690B (en) Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant
WO2007072092A3 (en) New phenanthridine derivatives as bradykinin antagonists
BRPI0506535A (pt) pirroles bis-indole úteis como agentes anti-microbiais
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
WO2009041786A3 (en) Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper longum for the prevention and treatment of inflammatory disease
WO2008024970A3 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
WO2006005578A3 (en) Solid pharmaceutical composition comprising mirtazapine
CY1110787T1 (el) Νεα μορφινικα παραγωγα
TH109864B (th) องค์ประกอบทางเภสัชกรรมแบบฉีดได้ที่ถูกทำแห้งแบบเยือกแข็งของอนุพันธ์กึ่งสังเคราะห์ของวินคา อัลคาลอยด์ ซึ่งเสถียรที่อุณภูมิห้อง
TH109864A (th) องค์ประกอบทางเภสัชกรรมแบบฉีดได้ที่ถูกทำแห้งแบบเยือกแข็งของอนุพันธ์กึ่งสังเคราะห์ของวินคา อัลคาลอยด์ ซึ่งเสถียรที่อุณภูมิห้อง
WO2007114946A3 (en) Acid-sensitive linkers for drug delivery

Legal Events

Date Code Title Description
FG Grant or registration